March 03, 2015 7:08 AM ET


Company Overview of Aptuscan Ltd

Company Overview

Aptuscan Ltd., a biotechnology company, develops engineered proteins for pharmaceutical, biotechnology, and diagnostic companies. The company focuses on the development of Scannins binding agents for the diagnosis and treatment of disease. Its products represent a resource for the identification of binding agents for the development of therapeutics or diagnostics, or as research reagents. The company was founded in 2008 and is based in Leeds, United Kingdom. As of January 9, 2012, Aptuscan Ltd operates as a subsidiary of Avacta Group Plc.

Leeds Innovation Centre

103 Clarendon Road

Leeds,  LS2 9DF

United Kingdom

Founded in 2008


44 1133 845 858


44 1133 845 826

Key Executives for Aptuscan Ltd

Interim Chief Executive Officer
Founder and CSO
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
CYP Design Ltd. Europe
Gendaq Limited Europe
Adaptimmune Limited Europe
Antoxis Limited Europe
MedPharm Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aptuscan Ltd, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at